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Abstract  
Background.  
The relative importance of individual and country-level factors influencing access to 
diagnosis and treatment for depression across the world is fairly unknown.  
Methods.  
We analysed cross-national data from the WHO World Health Surveys. Depression 
diagnosis and access to health care were ascertained using a structured interview. 
Logistic Bayesian Multilevel analyses were performed to establish individual and country 
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level factors associated with: (1) receiving a diagnosis and (2) accessing treatment for 
depression if a diagnosis was ascertained. 
 
Results.  
The sample included 7,870 individuals from 49 countries who met ICD-10 criteria for 
depressive episode in the past 12 months. A third (32%) of these individuals had ever 
been diagnosed with depression in their lifetime. Among those diagnosed with 
depression, 66% reported to have ever received treatment for depression. Although 
individual factors were more important determinants of access to treatment for 
depression, country-level factors explained 27.6% of the variance in access to diagnosis 
and 24.1% in access to treatment. Access to treatment for depression improved with 
increasing country income. Female gender, better education, the presence of physical co-
morbidity, more material assets, and living in urban areas were individual level 
determinants of better access.  
 
Limitations.  
Data on other contextual factors was not available. Unmet need was likely 
underestimated, since only lifetime treatment data was available. 
 
Conclusion.  
This study highlights major inequalities in access to a diagnosis and treatment of 
depression. Unlike the prevalence of depression, where contextual factors have shown to 
have less importance, a significant proportion of the variance in access to depression care 
was explained by country-level income.  
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Introduction 
Despite the worldwide public health importance of depression, it is often not identified or 
treated adequately (De Silva et al., 2014; Demyttenaere et al., 2004; Ferrari et al., 2013; 
Rai et al., 2013; Vos et al., 2012; Wang et al., 2007a). In fact, poor access to care has 
been identified as one of the key challenges for mental health systems in Low-and-Middle 
Income countries (LMIC) (Patel et al., 2016a). 
To improve access to mental health care, it is crucial to understand which individual and 
contextual factors influence this process. Traditionally, the focus has been on studying 
individual determinants of help-seeking and access to care. Previous studies suggest that 
factors such as low socio-economic status (Bleich et al., 2012) and male sex (Susukida et 
al., 2015) are associated with decreased service use. Poor mental health literacy (Wei et 
al., 2015), stigma and fear of disclosure (Clement et al., 2015) and self-reliance (Gulliver 
et al., 2010), for example, are important barriers to help-seeking. These individual factors 
also interact with each other, so that stigma impacts some groups, such as men and 
young people, more than others (Clement et al., 2015).   
However, contextual factors, such as country income and economic development may 
also influence access to services. Some studies suggest poorer countries are less likely to 
offer access to treatment for depression (Demyttenaere et al., 2004; Ferrari et al., 2013; 
Rai et al., 2013; Thornicroft et al., 2016). For example, in India, only 5% of persons with a 
common mental disorder had sought help (Sagar et al., 2017), whereas in Japan the 
corresponding figure is 22% (Ishikawa et al., 2016). Other potentially important contextual 
factors influencing access to treatment could be the health care system, and more 
specifically the kind of mental health services available. Considering that no individual-
based interventions, such as improving mental health literacy, have succeeded in 
improving help-seeking, it is particularly important to focus on studying contextual factors 
(Gulliver et al., 2012). 
Cross-country comparisons could potentially clarify the role of these contextual factors 
after accounting for individual variables. Unfortunately, few studies exist where both 
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individual and contextual variables are available, and when there are, these studies 
include only a limited number of countries, limiting the possibility to explore the 
contribution of contextual factors (Kohn et al., 2004; Wang et al., 2007a).  
In addition, these determinants may be different for different phases of the help-seeking 
process, namely obtaining a diagnosis, and receiving treatment. In resource-poor settings, 
reaching a diagnosis may not necessarily lead to receiving treatment. Most previous 
studies have focused on either identification or treatment, but not provided a combined 
assessment of both. Access to obtaining a diagnosis and treatment may have different 
determinants, particularly in resource-poor settings. 
This study aims to examine differences between and within countries in the likelihood of 
being diagnosed and accessing treatment among persons with depression in order to 
assess the relative contribution of several individual and contextual level factors in 
determining access to treatment. In particular, we investigated Gross National Income 
(GNI) as a determinant of access to health care for depression. 
 
Methods 
The World Health Surveys 
The World Health Surveys were carried out by the World Health Organisation (WHO) in 
2002-2003 in a sample of countries representing all regions of the world (Ustun et al., 
2003). The aim of the surveys was to allow worldwide comparisons of health outcomes 
using valid, reliable and comparable methods. In all participant countries the surveys were 
implemented using a representative, stratified random and probabilistic multi-stage 
sampling design of population ≥18 years, including institutionalised persons. 
Questionnaires were developed by the WHO in consultation with international and local 
experts and translated to local languages. The interviews were conducted after informed 
consent and performed face to face by trained interviewers. Detailed information about 
the World Health Surveys including the survey tools, sampling guidelines and procedures, 
and country statistics, is available elsewhere (http://www.who.int/healthinfo/survey/en/). 
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The individual response rates ranged between 63% in Israel to 99% in the Philippines, 
with an overall estimate of 98·5% for the surveys as a whole. We used data from 49 out of 
71 countries that had information on all key variables of interest (supplementary table 1). 
These included 14 low-income, 13 middle-lower income, 11 middle-upper income, and 11 
high-income countries according to World Bank criteria.   
 
Independent assessment of depression  
People who had suffered from an episode of depression during the past 12 months were 
identified using the WHO World Mental Health Survey version of the Composite 
International Diagnostic Interview (CIDI) (Kessler et al., 1998) linked to a validated 
diagnostic algorithm using the International Classification of Disease 10th (ICD-10) criteria 
(Organization, 1992). This version of the CIDI does not distinguish between types of 
depression but it includes all depressive disorders as a single category (major depressive 
disorder, dysthymia and depression NOS). 
 
Access to health care for depression 
First, we selected those individuals who met criteria for a depressive episode over the last 
12 months as mentioned above. Subsequently we used two approaches to estimate 
access to health care: 1) we estimated the proportion of depressed individuals who also 
reported having received a diagnosis of depression in their lifetime (have you ever been 
diagnosed with depression?). This variable most likely implies access to health care in 
view that only a health professional can confer such a diagnosis. These individuals will be 
referred to as ‘identified cases´. 2) Among those with a confirmed diagnosis of 
depression, we estimated the proportion that also acknowledged receiving treatment for 
depression in their lifetime (‘have you ever been treated for depression?’). These 
individuals will be referred to as ´treated cases´. There are a varying definitions and 
frameworks of ‘access to health care’, usually involving a range of concepts such us 
utilization, contact, true and evaluated need, satisfaction, affordability, acceptability, etc. 
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(Andersen, 1995; Bradshaw, 1972; Shengelia et al., 2005)(Pechansky and Thomas, 
1981). In our study, we opted to consider access in terms of whether those who need care 
(in our case diagnosis or treatment) receive it or not (Aday and Andersen, 1974; 
Donabedian, 1972; Tanahashi, 1978). In other words, utilization of healthcare services in 
case of a normative need, i.e. meeting criteria for a condition, to use health services 
(Shengelia et al., 2005). 
 
Individual socio-demographic and clinical measures 
Household spending:   
Participants estimated their total household expenditure in the previous month in their 
local currency, followed by questions related to expenditure in specific areas including 
food, housing, and healthcare amongst other expenses. A previous analysis of the World 
Health Surveys showed the aggregate of the expenditures reported in these areas to be 
consistent with the total reported household expenditure (Xu et al., 2009). The total 
monthly household expenditure was divided by the number of individuals in the household 
to calculate monthly per-capita household spending. For the analysis, we divided 
individuals into quintiles of household spending for each country, using lower spending as 
reference.  
Material assets index:  
We used responses regarding ownership of 9 household assets (television, washing 
machine, dishwasher, mobile phone, fixed telephone, computer, refrigerator, bicycle, and 
car). Probabilities of a household having each of the above assets for each specific 
country were calculated. Country specific standardised scores were then calculated for 
each household reflecting the sum of the complements of the probability of having each 
asset in that country. We stratified the scores in two categories: below the country-mean 
and above the country-mean (with a higher number of assets as reference category) 
(Ferguson et al., 2003; Rai et al., 2013).  
Education:  
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The reported number of years of completed education was categorised into <8, 8-12, and 
>12 years of education.    
Occupation:  
We used three categories: higher level or professionals /managers, other manual and 
non-manual workers, and those not working for pay.  
Demographic variables:  
Age, gender, and marital status (currently married or cohabiting, separated or divorced, 
never married, and widowed) and area of residence (urban or rural) were included as 
demographic variables. 
Physical comorbidity:  
This variable identified depressed individuals who had also received one or more 
diagnoses for other chronic diseases (diabetes, angina, arthritis, and asthma). The 
variable was coded dichotomously. 
 
Country-level measures 
Gross National Income (GNI):  
We used data from the World Bank (http://data.worldbank.org/ indicator) to compile the 
2002 GNI per capita for each country in US$ adjusted according to purchasing power 
parity (PPP). GNI measures the total value produced in the country, plus income from 
other sources, less similar payments made to other countries (Lequiller and Blades, 
2006). In our data, this varied from US$500 in Ethiopia to US$47,730 in Luxembourg. We 
log-transformed this variable for analysis in an attempt to linearize its relationship with 
depression (Lynch et al., 2000).  
 
Analysis 
All analyses involved only the sub-sample of individuals classified as with an episode of 
depression during the last 12 months according to ICD-10 criteria. Only persons with 
complete data were included in the analyses. Supplementary table 8 presents a 
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comparison of the results with complete data and including those with some missing data. 
 
Firstly, the weighted percentage of access to mental health care services (i.e. 
identification and among these those who also reported treatment) was calculated for 
each country. Weights represented the inverse probability of selection of an individual in 
each country. These estimates were calculated using the software R, version 2.10.1. 
Secondly, we estimated the relative importance of country level factors on access to 
health care (diagnosis and treatment). For this, we carried out multilevel logistic 
regressions and estimated two main indices: Variance Partitioning Coefficient (VPC) and 
Median Odds Ratio (MOR). The VPC quantifies the proportion of country level variance 
over the total model variance. We used the ‘latent variable method’ in which the variance 
of the lower level (in our case the individuals) is fixed as equal to 3.29 (Merlo et al., 2006; 
Rasbash et al., 2009). The VPC is commonly reported in multilevel analysis, but may vary 
depending on the prevalence of the outcome, making comparisons difficult.  In order to 
overcome this difficulty, we estimated the MOR, which allows better comparisons when 
the prevalence of the outcome differs. The MOR represents “the median value of the odds 
ratio between the country at highest risk and the country at lowest risk when randomly 
picking out two countries” (Merlo et al., 2006).  The MOR can be interpreted as the 
median change in likelihood of accessing treatment if an individual moved to another 
country. Higher MOR indicates larger differences between compared countries. 
 
In all instances we performed multilevel logistic regression models and reported odds 
ratios (OR) with 95% confidence intervals (95%CI). Crude and adjusted odd ratios were 
estimated. Interactions among variables were also explored.  All the multilevel regression 
models were estimated initially using Restricted Iterative Generalised Least Squares 
(RIGLS) methods and then using Markov Chain Monte Carlo procedures using MLWin 
2.8. All the models were run until when we achieved at least an effective sample size of 
200 (usually more than 100,000 chains). Since MLWin when operating in MCMC mode 
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does not allow the use of sampling weights, we undertook a sensitivity analysis to 
evaluate the impact of not using weights in the multilevel analysis. In order to assess this 
we carried out logistic regression models including weights using the R software. In an 
attempt to compensate for the absence of a multilevel structure we included the variable 
country in these models as a fixed effect and re-estimated all models where it was 
possible to do so (Bell and Jones, 2015). 
Results 
Complete data for those who met criteria for ICD-10 depressive episode during the last 12 
months was available for 7,870 individuals living in 49 countries, corresponding to 6.9% 
[95%CI 6·7 – 7·2%] of the weighted eligible sample (133,501 persons).  Including cases 
with missing values in some of the variables, there were 172,513 persons of whom 10,866 
had depression, equivalent to a weighted 7,0% [6.7 – 7.3] prevalence of depression. In 
the analyses, only persons with no missing data were included. 
Out of these depressed people, 2,342 (32.0% [95%CI 29.8 – 34.2%]) reported having 
received a diagnosis of depression in their lifetime (‘identified cases’), and 1,618 (21.9% 
[95%CI 19.8 – 24·0%] of all cases or 65.7% [95%CI 61.8% – 69.6%] of the ones who had 
received a diagnosis) acknowledged they had accessed treatment (‘treated cases’). 
Figure 1 shows the proportion of ‘cases identified’ whilst Figure 2 the proportion of ‘cases 
treated’ among the ‘identified cases’ by countries grouped according to the World Bank 
classification based on Gross National Income.  The same data is presented numerically 
in Supplementary tables 5-6. Supplementary table 7 presents the proportion of ‘treated 
cases’ out of all cases of depression. For both ‘identified’ and ‘treated’ cases, a large 
variability between countries grouped according to income levels was observed. In 
addition, the figures display a trend indicating less access to health care for depression 
among countries or group of countries with lower incomes. Country-correlation between 
‘identified’ and ‘treated’ cases was low (r= 0.40, p-value=0.004). 
These trends were further confirmed when we plotted the log-relationship between per-
capita Gross National Income by country and the proportion of ‘identified’ and ‘treated’ 
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cases (Figures 3a and 3b). The correlation was stronger for ‘identified cases’ but still 
persisted for ‘treated cases’.   
When examining individual variables, female sex, being separated or divorced, higher 
levels of education, or having any co-morbidity were positively associated with having 
been ‘identified’ as case of depression. On the contrary, those with a material assets 
index below the country-mean, widowed, or living in a rural area were associated with a 
lower likelihood of being ‘identified’ as cases of depression (Table 1). 
Among those ‘identified’ as cases of depression, those with higher spending levels were 
more likely to receive treatment. Older people also had higher odds of receiving 
treatment. Individuals belonging to the group below the country-mean on the material 
assets index and having co-morbidity were less likely to have received treatment for 
depression (Table 1). 
We observed a large variance among countries for both ‘identified’ and ‘treated’ cases. 
The VPC among countries represents 27·6% (country variance 1.25 (SE 0.27); MOR 2·90 
[95%CI 2.24 - 3.57]) and 24·1% (country variance 1.04 (SE 0.27); MOR 2·64 [95%CI 1.97 
- 3.29]) for ‘identified’ and ‘treated’ cases respectively. These values show that 
approximately a quarter of mental health care access depends on country level factors, 
whilst the rest is attributable to individual variability. The MOR indicates that the median 
difference in the odds of access to identification and treatment between two countries are 
on average 2.9 and 2.6-fold. 
The VPC for treated cases ranged from 5.1% (country variance 0.18 (SE 0.22); MOR 1.49 
[95% Creditable Intervals 0.62 - 2,11]) for high-income countries to 26.6% (country 
variance 1.19 (SE 0.64); MOR 2.82 [95% Creditable Intervals 0.78 - 4.42]) in low-income 
countries, indicating increasing importance of country level factors with decreasing 
country income, whereas the VPC did not vary in a consistent way for identified cases 
across country income groups (Supplementary Tables 3-4).  
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Discussion 
This study using data from a large standardised multi-country survey including 49 
countries confirms that the majority of individuals with depression are not identified and 
that a significant percentage of those identified with depression go untreated. 
Approximately one third of people who had a depressive episode in the past 12 months 
had been identified, and only around a fifth received treatment during their lifetime. Our 
findings also show a large gradient of access to treatment, from 7·1% in low-income 
countries to 66·4% in high-income countries, with an important variability within each 
country income group. As in previous studies, individual level variables seem most 
important in determining access to mental health care; in particular, socio-economic status 
is a powerful determinant of access to health care for depression. A large proportion of 
the variance in access to mental health services was explained at country level. This is in 
contrast with lower variance coefficients in the prevalence of depression across countries 
we have reported previously (Rai et al., 2013).  
 
Notably, both access to diagnosis and treatment were inquired for lifetime, and therefore 
the treatment gap for the current episode of depression is likely underestimated.  
 
Access rates in earlier studies 
These results are reasonably consistent with previous studies using different 
methodologies (Kohn et al., 2004; Wang et al., 2007a) but our findings show even more 
contrasting differences across countries with different gross national incomes. The World 
Mental Health Survey (WMHS), including 15 countries, found a range of access to health 
care for depression between 8.1% for middle and low-income countries to 29.3% for high-
income countries (Ormel et al., 2008). Further, only 16.5% received treatment that was 
considered minimally adequate (Thornicroft et al., 2016). A literature review of 37 national 
and community-based studies also found wide variability in treatment access for 
depression across countries (Kohn et al., 2004). However, in this review of a 
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heterogeneous sample of studies, the treatment gap for major depression was 56%, with 
wide variation, similar to our findings. No analysis according to levels of economic 
development of the countries involved was performed, but the gap was smaller in the 
European region (45%) than in the Americas (57%) or Africa (67%). The higher average 
rate of access to mental health care in this study, compared to our finding, is probably 
explained by the inclusion of mainly middle- and high-income countries. 
 
Access to diagnosis vs. access to treatment 
The WMHS used different definitions of access to treatment, including any service 
utilisation in past 12-months, and separately attending to follow-up visits (at least two 
visits: one for diagnosis or assessment, and other for onset of treatment or control) (Wang 
et al., 2007b). In keeping with the findings of this previous study, we found that a first 
contact with health services does not always guarantee access to treatment. Moreover, 
the country-correlation between ‘identified’ and ‘treated’ cases was lower than expected, 
further supporting our findings.  
 
In a few countries, the coverage for treatment was estimated at 100% among those 
identified, but this needs to be interpreted with caution because of low number of 
observations. In most countries, however, a large proportion of those identified did not 
receive treatment. This phenomenon could be related to lack of resources allocated for 
mental health to provide treatment, patients’ failure to follow up on recommended care, or 
other reasons of either the patient or health care provider to refuse treatment, such as 
negative attitudes towards depression. Unfortunately, this dataset does not provide further 
explanation for this discrepancy. 
 
Contextual factors 
The differences between countries in access to diagnosis or treatment for depression 
were larger than differences in prevalence of depression: the Mean Odds Ratio (MOR), 
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which represents the median difference between two countries, was 2.0 for prevalence of 
depression in our previous study (Rai et al., 2013), and 2.6 and 2.9 for access to health 
care (treatment and identification, respectively). This suggests that country-level factors 
have less influence on the prevalence of depression, but are more important determinants 
of access to health care.  
 
The relative contribution of country level factors as measured by the Variance Partitioning 
Coefficient (VPC) was high, 28% for ‘identified’ and 24% for ‘treated’ cases. This means 
that country level factors, such as country income which is likely to impact significantly in 
the coverage and quality of health systems, might explain approximately one quarter of 
the variability in access to health care for depression, whereas individual factors, such as 
individual level of education or being separated or divorced explained the remaining three 
quarters of this variability. A much larger proportion of the variance in access to health 
care for depression was explained at country level than when examining variations in the 
prevalence of depression, where country-level factors explained only 13.5% of the 
variance (Rai et al., 2013). 
The impact of country-level factors on access to treatment appeared to differ by country 
income level: the MOR for high-income countries was 1.5, while for low-income countries 
it was 2.8. Nevertheless, for access to diagnosis, the MOR was relatively homogeneous 
across country income groups. Additionally, the correlation we found between the 
proportion of ‘identified cases’ of depression and country GNI was strong, and this 
correlation remained for access to treatment among those ‘identified cases’. 
This implies that country income level may have a differential impact at different stages in 
the pathways to care, either access to diagnosis or treatment. However, the heterogeneity 
of access, especially to treatment, was higher in low-income countries than in the other 
countries: within the same range of low GNI, there were countries with relative high but 
also low access to treatment. This heterogeneity observed only in low-income countries 
and only in treatment could be explained by the fact that access to treatment is more 
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sensitive to arrangement of the health care delivery in contexts of similar economic 
resources (Mills 2014). This could be especially significant in low-income countries where 
the resources are scarce and small improvements can have a large impact. 
 
Individual factors 
However, individual factors still remain more important in explaining access to health care 
than country-level factors. This is consistent with findings from the WMHS where 
individual factors, such as attitudinal barriers, were more important barriers to help 
seeking than structural barriers, such as costs or unavailability of appointments (Wang et 
al., 2007a). 
Some individual variables were associated with both higher prevalence in our previous 
study and better access in this study, whereas others were associated with higher 
prevalence but lower access. For instance, women and separated or divorced persons 
had both increased prevalence and access to treatment. However, having lower levels of 
education and material assets were associated with increased prevalence and lower 
access, a combination that accentuates the burden of depression.  
Increased spending (proxy of income) was somewhat surprisingly associated with higher 
prevalence rates in our previous study, and strongly associated with access to treatment 
although not for detection in the present study. This variable is complex to interpret in so 
far as reflecting not only income levels but also needs and decisions about spending. Of 
the different measures of SES, higher education was associated with detection, but higher 
spending and better assets were associated with treatment. These findings suggest that 
socioeconomic status might impact access in different ways: education might allow the 
person to recognise symptoms of depression as something warranting medical attention, 
whereas material assets and income provide the means to pay for treatment. 
Comorbidity with physical conditions was another individual variable associated with 
access, positively for detection and negatively for treatment. Previous literature has also 
shown controversial results exploring association between comorbidity and access 
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(Menear et al., 2015). It is possible that persons with depression and other medical 
conditions are identified when they are in contact with health services for their other 
conditions, but treatment options are more limited due to their health status. However, this 
finding requires further study and clarification. 
 
Strengths and Limitations 
Among the strengths of this study, the large sample size representative of countries 
across all levels of economic development is noteworthy. Depression was identified using 
a validated questionnaire embedded in a face-to-face interview, and various individual 
level socioeconomic measures were available. We used multilevel methods, which are the 
most appropriate approach to account for any country level clustering of observations, 
and simultaneously study contextual and individual determinants of access to care for 
depression.   
 
Despite the use of comparable methods across the countries, it is possible that people in 
different countries may conceptualise and answer survey questions differently and 
therefore measurement biases, both in the estimates of access to care for depression and 
its determinants, cannot be ruled out (Epidemiology, 2000a, b; Phillips et al., 2009). In 
particular, it is possible that in some contexts health care providers might not refer to the 
condition as ‘depression’, and therefore the self-report on receiving diagnosis and/or 
treatment for depression might not be reliable. Similarly, it is possible that some persons 
reported to have been diagnosed with depression, even if the assessment was given by 
someone else than a medical professional. If this were the case, we would be 
overestimating the access to obtain a diagnosis of depression by a health professional. 
Further, the timeframe for diagnosis in the interview (12 months) and for access to care 
(lifetime) were different, because no data on access during the past 12 months was 
available. This definition underestimates the unmet need, as treatment may have been 
received during a previous episode instead of the current one. On the other hand, we did 
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not consider those who had received treatment without having been diagnosed. However, 
they were a small group: in total 35 persons in the whole dataset 
 
Although we analysed income data at a country level, there might be other contextual 
factors, such as regional differences within the countries or factors related to health care 
systems, which may contribute to the unexplained variance. We were not able to include 
all countries that participated in the World Health Surveys due to missing data; however, 
the 49 countries included represent all regions and levels of income. Among the included 
countries, we could not rule out systematic patterns of missingness, which could lead to 
selection bias.  
Finally, the data were collected in 2002-2003, and may not entirely represent current 
situations in some countries; nevertheless, we are not aware of any major improvements 
at a global scale in terms of access to care for depression since then. This is the most 
recent available dataset of this magnitude, and as such best suited to model global 
patterns of access to care for depression.  
Conclusions 
Whether or not a depressed individual has access to professional help is mostly 
determined by individual factors, socio-economic status prominent among these. 
However, also contextual factors, especially country income, seem to play an important 
role, which increases in importance with reducing country income. This highlights the 
double burden of low individual socio-economic status and living in a low-income country, 
both of which contribute to a much lower access to help in the face of a mental disorder. 
A priority in global mental health is “to massively increase opportunities for people with 
mental, neurological and substance use disorders to access services without the prospect 
of discrimination or impoverishment and with the hope of attaining optimal health and 
social outcomes” (Patel et al., 2016a). Several international efforts exist to support poorer 
countries in delivering effective, evidence-based mental health care (Patel et al., 2016b; 
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Shidhaye et al., 2015). It is to be hoped that these statements and efforts will materialize 
in the years to come. 
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Table 1. Individual-level socioeconomic correlates of access to diagnosis* and 
treatment** of depression: multilevel logistic regression analysis of pooled sample. 
 
Access to 
Diagnosis 
of 
Depressiona 
Access to 
Diagnosis of 
Depressiona 
Access to 
Treatment 
of 
Depression
b 
Access to 
Treatment of 
Depressionb 
 
Crude 
variables 
Adjusted 
variables 
Crude 
variables 
Adjusted 
variables 
 OR 
CI(2.5 
- 
97.5
%) OR 
CI(2.5 
- 
97.5
%) OR 
CI(2.5 
- 
97.5
%) OR 
CI(2.5 
- 
97.5%
) 
Age (years) 1.01 
1.00-
1.01 1.00 
1.00-
1.01 1.01 
1.00-
1.01 1.01 
1.01-
1.02 
Sex (males reference) 1.34 
1.19-
1.51 1.32 
1.16-
1.50 1.15 
0.92-
1.44 1.24 
0.98-
1.58 
Place (Urban zones 
reference) 0.72 
0.64-
0.81 0.78 
0.69-
0.89 0.82 
0.66-
1.02 1.03 
0.81-
1.31 
Currently married or 
cohabiting 1.00 - 1.00 - 1.00 - 1.00 - 
Separated or divorced 1.27 
1.04-
1.55 1.26 
1.03-
1.54 1.18 
0.83-
1.68 1.15 
0.8-
1.67 
Never married 0.92 
0.79-
1.08 1.01 
0.85-
1.20 0.78 
0.59-
1.04 0.89 
0.66-
1.21 
Widowed 0.94 
0.81-
1.10 0.79 
0.66-
0.93 1.03 
0.78-
1.37 0.91 
0.66-
1.25 
Education (<8 years) 1.00 - 1.00 - 1.00 - 1.00 - 
Education (8 -12 years) 1.06 
0.92-
1.22 1.09 
0.93-
1.27 1.35 
1.04-
1.77 1.23 
0.91-
1.64 
Education (>12 years) 1.30 
1.08-
1.55 1.28 
1.03-
1.58 1.71 
1.21-
2.42 1.43 
0.96-
2.15 
Material-Assets (Index > than 
mean reference) 0.80 
0.71-
0.90 0.85 
0.75-
0.97 0.55 
0.44-
0.69 0.65 
0.51-
0.83 
Quintile 5 (lowest spending) 1.00 - 1.00 - 1.00 - 1.00 - 
Quintile 4 0.92 
0.76-
1.11 0.90 
0.75-
1.09 1.15 
0.82-
1.60 1.11 
0.78-
1.56 
Quintile 3 1.05 
0.87-
1.26 0.95 
0.79-
1.15 1.60 
1.15-
2.23 1.54 
1.100-
2.17 
Quintile 2 1.07 
0.90-
1.27 0.96 
0.80-
1.15 1.78 
1.29-
2.47 1.57 
1.12-
2.21 
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Quintile 1 (highest spending) 1.40 
1.18-
1.66 1.18 
0.99-
1.42 2.21 
1.62-
3.03 1.81 
1.29-
2.54 
Occupation: High 
professionals 1.00 - 1.00 - 1.00 - 1.00 - 
Non manual and manual 
workers 0.79 
0.59-
1.04 0.99 
0.73-
1.35 0.73 
0.43-
1.24 1.24 
0.68-
2.29 
Occupation: Not Working for 
pay 0.94 
0.71-
1.24 1.07 
0.79-
1.44 0.67 
0.40-
1.12 1.08 
0.60-
1.97 
Comorbidity 
2.05 
1.84-
2.30 
2.08 
1.85-
2.34 
0.84 
0.68-
1.02 
0.79 
0.63-
0.98 
 
n 
level 
1 7,870 
n 
level 
1 7,870 
n 
level 
1 2,342 
n 
level 
1 2,342 
 
n 
level 
2 49 
n 
level 
2 49 
n 
level 
2 47 
n 
level 
2 47 
a. Access to Diagnosis of Depression: life-time access to Diagnosis of cases with 
depression during last year 
b. Access to Treatment of Depression: life-time access to Treatment of cases with 
diagnosis in those had depression during last year 
CI: Confidence Interval 
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Figure 1. Estimated country-level proportions of ‘identified cases’ of depression during the 
past 12 months, grouped by economic development (World Bank criteria). 
 
(a) High-income countries (HIC)   (b) Upper–middle-income countries (UMIC) 
               
 
 
 
 
  
 
(c) Lower-middle- income countries           (d) Low-income countries 
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11. Sweden, 10. France, 9. Finland, 8. 
Luxembourg, 7. Spain, 6. Portugal, 5. 
Ireland, 4. Estonia, 3. Croatia, 2. Czech 
Republic, 1. Slovakia , 0. Pooled HIC 
11. Uruguay, 10. Brazil, 9. 
Bosnia/Herzegovina, 8. South Africa, 7.  
Namibia, 6. Mauritius, 5. Latvia, 4. 
Malaysia, 3. Dominican Republic, 2. 
Kazakhstan, 1.  Russia, 0. Pooled UMIC 
13. Swaziland, 12. India, 11. Ecuador, 
10. Paraguay, 9. Georgia, 8. 
Philippines, 7. Tunisia, 6. Ukraine, 5. 
Pakistan,  4. Morocco,  3. China, 2. Sri 
Lanka, 1. Cote d’Ivoire, 0. Pooled LMIC 
14. DR Congo, 13. Lao PDR, 12. Kenya, 
11. Mauritania, 10. Ghana, 9. Zambia, 8. 
Burkina Faso, 7. Senegal, 6. Chad, 5. 
Mali, 4. Bangladesh, 3. Malawi, 2. 
Vietnam, 1. Comoros, 0. Pooled LIC 
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Figure 2. Estimated country-level proportions of ‘treated cases’ among ‘identified cases’ 
of depression during the past 12 months, grouped by economic development (World Bank 
criteria). 
 
(a) High-income countries (HIC)   (b) Upper–middle-income countries (UMIC) 
                 
 
 
  
 
 
 
(c) Lower-middle- income countries           (d) Low-income countries 
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1. Malaysia, 0. Pooled UMIC 
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0. Pooled LIC 
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Figure 3. The proportion of (a) ‘identified cases’ among persons with depression during 
the past 12 months, and (b) ‘treated cases’ among the ‘identified cases’ during the past 12 
months, by country-level measures of Gross National Income per capita PPP. 
 
(a) ‘Identified cases’ among persons with depression during the past 12 months 
 
 
(b) ‘Treated cases’ among the ‘identified cases’ during the past 12 months 
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Highlights 
 Major inequalities exist in access to treatment for depression across countries. 
 One quarter of the variance in access is explained by country-level variation. 
 Individual factors are still the most important determinants of access to treatment.  
 We used one of the largest existing datasets to study determinants of access 
globally. 
 
